Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes
Open Access
- 1 December 1998
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 336 (2) , 429-436
- https://doi.org/10.1042/bj3360429
Abstract
Human liver dihydrodiol dehydrogenase (DD; EC 1.3.1.20) exists in isoforms (DD1, DD2 and DD4) composed of 323 amino acids. DD1 and DD2 share 98% amino acid sequence identity, but show lower identities (approx. 83%) with DD4, in which a marked difference is seen in the C-terminal ten amino acids. DD4 exhibits unique catalytic properties, such as the ability to oxidize both (R)- and (S)-alicyclic alcohols equally, high dehydrogenase activity for bile acids, potent inhibition by steroidal anti-inflammatory drugs and activation by sulphobromophthalein and clofibric acid derivatives. In this study, we have prepared chimaeric enzymes, in which we exchanged the C-terminal 39 residues between the two enzymes. Compared with DD1, CDD1-4 (DD1 with the C-terminal sequence of DD4) had increased kcat/Km values for 3α-hydroxy-5β-androstanes and bile acids of 3–9-fold and decreased values for the other substrates by 5–100-fold. It also became highly sensitive to DD4 inhibitors such as phenolphthalein and hexoestrol. Another chimaeric enzyme, CDD4-1 (DD4 with the C-terminal sequence of DD1), showed the same (S)-stereospecificity for the alicyclic alcohols as DD1, had decreased kcat/Km values for bile acids with 7β- or 12α-hydroxy groups by more than 120-fold and was resistant to inhibition by betamethasone. In addition, the activation effects of sulphobromophthalein and bezafibrate decreased or disappeared for CDD4-1. The recombinant DD4 with the His314 → Pro (the corresponding residue of DD1) mutation showed intermediate changes in the properties between those of wild-type DD4 and CDD4-1. The results indicate that the binding of substrates, inhibitors and activators to the enzymes is controlled by residues in their C-terminal domains; multiple residues co-ordinately act as determinants for substrate specificity and inhibitor sensitivity.Keywords
This publication has 28 references indexed in Scilit:
- Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3α-hydroxysteroid/dihydrodiol dehydrogenaseStructure, 1997
- The C-Terminal Loop of Aldehyde Reductase Determines the Substrate and Inhibitor SpecificityBiochemistry, 1996
- 1.7 .ANG. Structure of FR-1, a Fibroblast Growth Factor-Induced Member of the Aldo-Keto Reductase Family, Complexed with Coenzyme and InhibitorBiochemistry, 1995
- Reduction of prostaglandin D2 to 9α,11β-prostaglandin F2 by a human liver 3α-hydroxysteroid/dihydrodiol dehydrogenase isozymeBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Aldose reductase inhibitors and their potential for the treatment of diabetic complicationsTrends in Pharmacological Sciences, 1994
- cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenaseBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1994
- An Anion Binding Site in Human Aldose Reductase: Mechanistic Implications for the Binding of Citrate, Cacodylate, and Glucose 6-PhosphateBiochemistry, 1994
- Identity of dihydrodiol dehydrogenase and 3α‐hydroxysteroid dehydrogenase in rat but not in rabbit liver cytosolFEBS Letters, 1984
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970